1 Product identity
Ingredient risk
Contains restricted ingredients
Menopause Formula No 1
BrandRealDose→Botanical Capsule 10 ingredients 1 banned 1 caution DSLD #182107Net contents: 60 Vegetarian Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2018-10-25
2 Ingredients (10)
IngredientGroupSafety
EstroG-100 Herb BlendProprietary Blend (Herb/Botanical)—
Phlomis umbrosa root extractPhlomis umbrosa—
Cynanchum wilfordii root extractCynanchum wilfordii—
Angelica gigas Nakai root extractKorean Angelica—
BioperineBlack Pepper—
Vegetable Capsulecapsule—
Vegetable CelluloseCellulose—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Ashwagandha 🇩🇰 🇧🇪 🇪🇺 — Banned April 2023 following DTU risk assessment. All products withdrawn.
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Ashwagandha — Banned in ≥1 country
⚠ Thyroid stimulation
⚠ HEPATOTOXICITY (rare but serious case reports)
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID182107
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2018-10-25
6 More from RealDose
View RealDose Safety Scorecard → 2 products
Omega-3 TG Fresh Lemon-Lime Taste7 Cite this page
Vancouver
Pkhakadze G. Menopause Formula No 1 — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 27]. Available from: https://supplement.ge/products/dsld-182107/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG